Cart (0 Items)
Your cart is currently empty.
View ProductsBrand | ProteoGenix |
---|---|
Product type | Elisa assay kits |
Size | 1 kit |
Product name | Monkeypox Virus (MPXV) H3L Antigen ELISA Kit |
---|---|
Delivery condition | Blue ice (+4°) |
Storage condition | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
Brand | ProteoGenix |
Size | 1 kit |
Reference | KPTX108 |
Note | For research use only. |
Sample type | Plasma, Serum |
Immunogen | H3L |
The Monkeypox Virus (MPXV) is a zoonotic virus that belongs to the Orthopoxvirus family. It is closely related to the variola virus, which is responsible for smallpox, and is known to cause a smallpox-like disease in humans. The virus was first identified in 1958 in monkeys and has since been found in a variety of animal species, including rodents, primates, and even domesticated pets. In humans, MPXV infection can range from mild flu-like symptoms to severe illness, and in some cases, can be fatal. Due to its potential for causing outbreaks and its similarity to smallpox, MPXV is considered a potential bioterrorism agent.
The H3L antigen is a major structural protein of MPXV and has been identified as a potential therapeutic target for developing vaccines and treatments against the virus. To facilitate research on this antigen, a Monkeypox Virus (MPXV) H3L Antigen ELISA Kit has been developed. This kit allows for the detection and measurement of H3L antigen in various biological samples, providing valuable information on the structure, activity, and potential applications of this important viral protein.
The H3L antigen is a 37 kDa protein that is encoded by the H3L gene of MPXV. It is a highly conserved protein that is found on the surface of the virus and is essential for viral entry into host cells. The H3L protein is composed of 334 amino acids and has a predicted molecular weight of 37 kDa. It contains a signal peptide, a transmembrane domain, and a cytoplasmic tail, which are all important for its function in viral entry and replication.
The H3L antigen is also known to have a conserved region that is similar to the receptor-binding domain of the variola virus, suggesting that it may play a similar role in viral attachment and entry. Additionally, the H3L protein has been found to have a high degree of homology with other Orthopoxviruses, such as vaccinia virus and cowpox virus, indicating its importance in the pathogenesis of these viruses.
The H3L antigen is a key player in the entry of MPXV into host cells. It has been shown to bind to the host cell surface receptor, which triggers a series of events that allow the virus to enter and infect the cell. The H3L protein is also known to interact with other viral proteins, such as the A27L protein, to facilitate viral entry and replication. Additionally, the H3L antigen has been found to be involved in the modulation of host immune responses, which may contribute to the pathogenesis of MPXV infection.
Due to its crucial role in viral entry and replication, the H3L antigen has been identified as a potential therapeutic target for developing vaccines and treatments against MPXV. By targeting this protein, it may be possible to prevent or limit viral entry and replication, thereby reducing the severity of the disease and improving patient outcomes.
The Monkeypox Virus (MPXV) H3L Antigen ELISA Kit has a wide range of applications in the field of MPXV research. It can be used to detect and quantify H3L antigen in various biological samples, including serum, plasma, and tissue lysates. This allows for the monitoring of viral load and the assessment of the efficacy of potential treatments in preclinical and clinical studies.
Furthermore, the MPXV H3L Antigen ELISA Kit can also be used to screen potential antiviral compounds and evaluate their ability to inhibit the activity of the H3
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.